Abstract CT084: A phase 1 study of LY4101174 (ETx-22), an antibody-drug conjugate targeting nectin-4, in patients with advanced or metastatic urothelial cancer and other solid tumors (trial in progress)Jonathan E. Rosenberg, Ahmad Awada, Armelle Viceneux et al.|Cancer Research|2024Cited by 9